1-6 of 6
Hua Jiang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Anti-CLL1 Chimeric Antigen Receptor T-Cell Therapy in Children with Relapsed/Refractory Acute Myeloid Leukemia

Hui Zhang, Pengfei Wang, Zhuoyan Li, Yingyi He, Wenting Gan, Hua Jiang
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (13): 3549–3555.
https://doi.org/10.1158/1078-0432.CCR-20-4543
Published: 01 July 2021
View article titled, Anti-CLL1 Chimeric Antigen Receptor T-Cell Therapy in Children with Relapsed/Refractory Acute Myeloid Leukemia
Open the PDF for Anti-CLL1 Chimeric Antigen Receptor T-Cell Therapy in Children with Relapsed/Refractory Acute Myeloid Leukemia in another window
Includes: Supplementary data
Journal Articles

Coexpression of IL7 and CCL21 Increases Efficacy of CAR-T Cells in Solid Tumors without Requiring Preconditioned Lymphodepletion

Hong Luo, Jingwen Su, Ruixin Sun, Yansha Sun, Yi Wang, Yiwei Dong, Bizhi Shi, Hua Jiang, Zonghai Li
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (20): 5494–5505.
https://doi.org/10.1158/1078-0432.CCR-20-0777
Published: 15 October 2020
View article titled, Coexpression of IL7 and CCL21 Increases Efficacy of CAR-T Cells in Solid Tumors without Requiring Preconditioned Lymphodepletion
Open the PDF for Coexpression of IL7 and CCL21 Increases Efficacy of CAR-T Cells in Solid Tumors without Requiring Preconditioned Lymphodepletion in another window
Includes: Supplementary data
Journal Articles

Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials

Donghua Shi, Yaoping Shi, Ahmed O. Kaseb, Xingxing Qi, Yuan Zhang, Jiachang Chi, Qing Lu, Huiping Gao, Hua Jiang, Huamao Wang, Daijing Yuan, Hong Ma, Hongyang Wang, Zonghai Li, Bo Zhai
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (15): 3979–3989.
https://doi.org/10.1158/1078-0432.CCR-19-3259
Published: 03 August 2020
View article titled, Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials
Open the PDF for Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials in another window
Includes: Supplementary data
Journal Articles

Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma

Huiping Gao, Kesang Li, Hong Tu, Xiaorong Pan, Hua Jiang, Bizhi Shi, Juan Kong, Hongyang Wang, Shengli Yang, Jianren Gu, Zonghai Li
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2014) 20 (24): 6418–6428.
https://doi.org/10.1158/1078-0432.CCR-14-1170
Published: 14 December 2014
View article titled, Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma
Open the PDF for Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma in another window
Includes: Supplementary data
Journal Articles

Analysis of MiR-195 and MiR-497 Expression, Regulation and Role in Breast Cancer

Dan Li, Yulan Zhao, Changxing Liu, Xiaona Chen, Yanting Qi, Yue Jiang, Chao Zou, Xiaolong Zhang, Shunying Liu, Xuejing Wang, Dan Zhao, Qiang Sun, Zhenbing Zeng, Andreas Dress, Marie C. Lin, Hsiang-Fu Kung, Hallgeir Rui, Ling-Zhi Liu, Feng Mao, Bing-Hua Jiang, Lihui Lai
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (7): 1722–1730.
https://doi.org/10.1158/1078-0432.CCR-10-1800
Published: 31 March 2011
View article titled, Analysis of MiR-195 and MiR-497 Expression, Regulation and Role in Breast Cancer
Open the PDF for Analysis of MiR-195 and MiR-497 Expression, Regulation and Role in Breast Cancer in another window
Includes: Supplementary data
Journal Articles

trans- 3,4,5′-Trihydroxystibene Inhibits Hypoxia-Inducible Factor 1α and Vascular Endothelial Growth Factor Expression in Human Ovarian Cancer Cells

Zongxian Cao, Jing Fang, Chang Xia, Xianglin Shi, Bing-Hua Jiang
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (15): 5253–5263.
https://doi.org/10.1158/1078-0432.CCR-03-0588
Published: 05 August 2004
View article titled, <em>trans-</em> 3,4,5′-Trihydroxystibene Inhibits Hypoxia-Inducible Factor 1α and Vascular Endothelial Growth Factor Expression in Human Ovarian Cancer Cells
Open the PDF for <em>trans-</em> 3,4,5′-Trihydroxystibene Inhibits Hypoxia-Inducible Factor 1α and Vascular Endothelial Growth Factor Expression in Human Ovarian Cancer Cells in another window